1. |
Iung B, Vahanian A. Epidemiology of acquired valvular heart disease. Can J Cardiol, 2014, 30(9): 962-970.
|
2. |
吴永健, 许海燕. 探索经导管主动脉瓣置换术的中国特色康复模式. 中华老年心脑血管病杂志, 2019, 21(7): 673-675.
|
3. |
Leon MB, Smith CR, Mack M, et al. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med, 2010, 363(17): 1597-1607.
|
4. |
Smith CR, Leon MB, Mack MJ, et al. Transcatheter versus surgical aortic-valve replacement in high-risk patients. N Engl J Med, 2011, 364(23): 2187-2198.
|
5. |
王圣, 黄乾海, 陈现杰, 等. 经导管主动脉瓣置入术后常见并发症及处理措施. 心肺血管病杂志, 2019, 38(5): 584-587.
|
6. |
党梦秋, 范嘉祺, 朱齐丰, 等. 《经导管主动脉瓣置换术中国专家共识(2020更新版)》解读. 心电与循环, 2021, 40(1): 1-5.
|
7. |
经导管主动脉瓣置换术中国专家共识编写组. 经导管主动脉瓣置换术中国专家共识. 中国介入心脏病学杂志, 2015, 23(12): 661-667.
|
8. |
Bekeredjian R, Krumsdorf U, Chorianopoulos E, et al. Usefulness of percutaneous aortic valve implantation to improve quality of life in patients >80 years of age. Am J Cardiol, 2010, 106(12): 1777-1781.
|
9. |
冯晔子, 张申伟, 马倩倩, 等. 主动脉瓣重度狭窄经导管主动脉瓣置换术后患者围术期效果观察. 心肺血管病杂志, 2019, 38(11): 1146-1149.
|
10. |
Landes U, Iakobishvili Z, Vronsky D, et al. Transcatheter aortic valve replacement in oncology patients with severe aortic stenosis. JACC Cardiovasc Interv, 2019, 12(1): 78-86.
|
11. |
Jadad AR, Moore RA, Carroll D, et al. Assessing the quality of reports of randomized clinical trials: Is blinding necessary? Control Clin Trials, 1996, 17(1): 1-12.
|
12. |
Stang A. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol, 2010, 25(9): 603-605.
|
13. |
Berkovitch A, Guetta V, Barbash IM, et al. Favorable short-term and long-term outcomes among patients with prior history of malignancy undergoing transcatheter aortic valve implantation. J Invasive Cardiol, 2018, 30(3): 105-109.
|
14. |
Mangner N, Woitek FJ, Haussig S, et al. Impact of active cancer disease on the outcome of patients undergoing transcatheter aortic valve replacement. J Interv Cardiol, 2018, 31(2): 188-196.
|
15. |
Watanabe Y, Kozuma K, Hioki H, et al. Comparison of results of transcatheter aortic valve implantation in patients with versus without active cancer. Am J Cardiol, 2016, 118(4): 572-577.
|
16. |
Biancari F, Dahlbacka S, Juvonen T, et al. Favorable outcome of cancer patients undergoing transcatheter aortic valve replacement. Int J Cardiol, 2020, 315: 86-89.
|
17. |
Guha A, Dey AK, Arora S, et al. Contemporary trends and outcomes of percutaneous and surgical aortic valve replacement in patients with cancer. J Am Heart Assoc, 2020, 9(2): e014248.
|
18. |
Tabata N, Al-Kassou B, Sugiura A, et al. Prognostic impact of cancer history in patients undergoing transcatheter aortic valve implantation. Clin Res Cardiol, 2020, 109(10): 1243-1250.
|
19. |
Tabata N, Al-Kassou B, Sugiura A, et al. Predictive value of the platelet-to-lymphocyte ratio in cancer patients undergoing transcatheter aortic valve replacement. JACC CardioOncol, 2019, 1(2): 159-169.
|
20. |
Zamorano JL, Lancellotti P, Muñoz DR, et al. 2016 ESC position paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines. Kardiol Pol, 2016, 74(11): 1193-1233.
|
21. |
Cubeddu RJ, Jneid H, Don CW, et al. Retrograde versus antegrade percutaneous aortic balloon valvuloplasty: Immediate, short- and long-term outcome at 2 years. Catheter Cardiovasc Interv, 2009, 74(2): 225-231.
|
22. |
Lieberman EB, Bashore TM, Hermiller JB, et al. Balloon aortic valvuloplasty in adults: Failure of procedure to improve long-term survival. J Am Coll Cardiol, 1995, 26(6): 1522-1528.
|
23. |
Yusuf SW, Sarfaraz A, Durand JB, et al. Management and outcomes of severe aortic stenosis in cancer patients. Am Heart J, 2011, 161(6): 1125-1132.
|
24. |
Samuels LE, Kaufman MS, Morris RJ, et al. Open heart surgery in patients with chronic lymphocytic leukemia. Leuk Res, 1999, 23(1): 71-75.
|
25. |
Chan J, Rosenfeldt F, Chaudhuri K, et al. Cardiac surgery in patients with a history of malignancy: Increased complication rate but similar mortality. Heart Lung Circ, 2012, 21(5): 255-259.
|
26. |
Van Mieghem NM, van der Boon RM, Nuis RJ, et al. Cause of death after transcatheter aortic valve implantation. Catheter Cardiovasc Interv, 2014, 83(7): E277-E282.
|
27. |
Kogoj P, Devjak R, Bunc M. Balloon aortic valvuloplasty (BAV) as a bridge to aortic valve replacement in cancer patients who require urgent non-cardiac surgery. Radiol Oncol, 2014, 48(1): 62-66.
|